# FDA recall D-1743-2019

> **Glenmark Pharmaceuticals Inc., USA** · Class III · drug recall initiated 2019-08-07.

## Product

Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%, 15 gram tubes, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Village: Kishanpura, Baddi Nalagarth Road, District: Solan, Himachal Pradesh-173205, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-298-17

## Reason for recall

Temperature Abuse: Complaints received of liquidy texture.

## Distribution

Nationwide with the United States

## Key facts

- **Recall number:** D-1743-2019
- **Recalling firm:** Glenmark Pharmaceuticals Inc., USA
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-08-07
- **Report date:** 2019-08-21
- **Termination date:** 2020-11-09

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Mahwah, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1743-2019

## Citation

> AI Analytics. FDA recall D-1743-2019. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-1743-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*